What is it about?
Low back pain is a common problem affecting people of all ages and backgrounds. It is caused by various factors, but one of the most significant is the degeneration of intervertebral discs (IVDs). To address this issue, researchers are developing regenerative therapies that can help to restore the function of the IVD. To develop and evaluate the effectiveness of these new therapies and treatments, researchers are using a variety of models. These models include in vitro cell studies using microfluidics, ex vivo organ studies coupled with bioreactors and mechanical test systems, and in vivo testing using a variety of large and small animals. Each model has advantages and limitations, and as models become more complex, while the physiological accuracy may increase, so too may the cost, time, and ethical constraints. Therefore, researchers must weigh the benefits and drawbacks of each model carefully and choose the best approach for their research goals.
Featured Image
Photo by CHUTTERSNAP on Unsplash
Why is it important?
When it comes to developing treatments for degenerative disc disease (DDD), it is crucial to understand how mechanical and biochemical factors interact with each other. By using models that intend to resemble the natural environment in the disc, researchers can better understand how loading affects the disc on a cellular and tissue level, both when DDD is present and when therapies or treatments are introduced. This can improve the speed and safety of developing effective therapies and treatments and provide them to patients suffering from back pain.
Perspectives
Read the Original
This page is a summary of: The role of biomechanical factors in models of intervertebral disc degeneration across multiple length scales, APL Bioengineering, May 2023, American Institute of Physics,
DOI: 10.1063/5.0137698.
You can read the full text:
Contributors
The following have contributed to this page